An observational study to evaluate drug utilization pattern and adverse drug reaction profile in radiotherapy and oncology section.

"Evaluation of Drug Utilization Pattern and Adverse Drug Reaction Profile in Radiotherapy and Oncology section of A Tertiary Health Care teaching hospital: A prospective, observational study"

Status

Active, not recruiting

Phases

Phase 4

Study type

Observational

Source

CTRI

Registry ID

CTRI/2016/11/007421

Enrollment

200

Registered

2016-11-02

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Adverse drug reaction profile and drug utilization pattern in radiotherapy and oncology section.

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.All the participants undergoing chemotherapy in day care centre during the study time period will be enrolled. 2.All participants receiving anti-cancer regimens, will be included in the study . ï?§3.Participants of any age group

Exclusion criteria

Exclusion criteria: Patients not receiving any kind of cancer chemotherapy

Design outcomes

Primary

Measure	Time frame
â?¢To analyze drug utilization pattern. â?¢To identify the ADRâ??s caused by anti-cancer drugs Timepoint: In morning OPD hours and in evening round ( 3days per week)for 2 year duration.	—

Secondary

Measure	Time frame
â?¢Information of patient like name, age, gender, weight, and address of patient. â?¢Information of drug, its dose, dosage form, mode of administration and total duration of therapy. â?¢Treatment according to STG( Standard treatment guidelines) or not. â?¢To determine ADRs due to multidrug anticancer regimens and to evaluate its causality , severity, preventability, whether it is reversible or irreversible and to study drug utilization pattern in cancer patients. Timepoint: In morning OPD hours and in evening round ( 3days per week)for 2 year duration.	—

Measure

Time frame

â?¢Information of patient like name, age, gender, weight, and address of patient. â?¢Information of drug, its dose, dosage form, mode of administration and total duration of therapy. â?¢Treatment according to STG( Standard treatment guidelines) or not. â?¢To determine ADRs due to multidrug anticancer regimens and to evaluate its causality , severity, preventability, whether it is reversible or irreversible and to study drug utilization pattern in cancer patients. Timepoint: In morning OPD hours and in evening round ( 3days per week)for 2 year duration.

—

Countries

India

Contacts

Public ContactDr CBTripathi

Government Medical College,Bhavnagar

cbrtripathi@yahoo.co.in09825951678

Outcome results